Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Missy Simpson
Observed name:
MISSY SIMPSON
Institution:
SomaLogic (United States)
Observed institution:
SomaLogic (United States)
ORCID:
0000-0002-9757-4427
Observed ORCID:
0000-0002-9757-4427
OpenAlex ID:
A5038534789
A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk
2022
·
Stephen A. Williams
, Rachel Ostroff
, et al.
·
Science Translational Medicine
·
105
Proteomic signatures for identification of impaired glucose tolerance
2022
·
Julia Carrasco-Zanini
, Maik Pietzner
, et al.
·
Nature Medicine
·
56
Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk
2023
·
Heather E. Dark
, Clare Paterson
, et al.
·
Annals of Neurology
·
24
PDF
1237-P: Proteomic Indicators of Metabolic Health in Diabetes and Social Vulnerability
2023
·
MISSY SIMPSON
, RACHEL OSTROFF
, et al.
·
Diabetes
·
1
Abstract 11650: Cardiometabolic Disease Protein Signatures and Response to GLP-1 Receptor Agonist in the EXSCEL Clinical Trial
2022
·
Rachel Ostroff
, Jennifer Green
, et al.
·
Circulation
·
1
Assessing the Clinical Utility of a Proteomics-based Cardiovascular Risk Test to Guide Risk-concordant Treatment in Patients With Type 2 Diabetes Mellitus
2024
·
Rosalynn Gill
, Missy Simpson
, et al.
·
Journal of the American College of Cardiology
The association between proteomically derived cardiovascular risk and incident dementia in a community cohort
2024
·
Roger Chang
, Missy Simpson
, et al.
·
Cerebral Circulation - Cognition and Behavior
Abstract 13902: Using a Proteomics-Based Cardiovascular Risk Test to Identify Systemic Changes in a Clinical Trial of Nonalcoholic Fatty Liver Disease
2023
·
Arun Sanyal
, Missy Simpson
, et al.
·
Circulation
Abstract 13105: Applying Proteomic CV and Kidney Prognosis Risk in T2D Patients to Identify High-Risk Patients
2023
·
Michael Hinterberg
, Missy Simpson
, et al.
·
Circulation
Abstract 13263: Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
2023
·
Jessica Chadwick
, Michael Hinterberg
, et al.
·
Circulation
Abstract 13915: Comparison of Proteomic CV Risk to Established ASCVD 10-year Risk Decision Points
2023
·
Michael Hinterberg
, Nelson P Trujillo
, et al.
·
Circulation
Abstract 13280: Proteomic Indicators of Cardiovascular Health Relate to Brain Volume and Dementia Risk
2022
·
Heather E Dark
, Clare Paterson
, et al.
·
Circulation
Abstract 11537: Progress Towards a Proteomic Surrogate Endpoint for Cardiovascular Outcomes
2021
·
Stephen A Williams
, Rachel Ostroff
, et al.
·
Circulation
Show more works
View as search
Works count:
13
Citation count:
187
H-index:
3
I10-index:
3
Year
Topic
Type